Primary endocrine resistance of ER+ breast cancer with ESR1 mutations interrogated by droplet digital PCR
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Primary endocrine resistance of ER+ breast cancer with ESR1 mutations interrogated by droplet digital PCR
Authors
Keywords
-
Journal
npj Breast Cancer
Volume 8, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-05-02
DOI
10.1038/s41523-022-00424-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)†
- (2020) F. Cardoso et al. ANNALS OF ONCOLOGY
- Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations
- (2018) Rinath Jeselsohn et al. CANCER CELL
- Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targets
- (2018) Leah A. Gates et al. ONCOGENE
- A Computational Assay of Estrogen Receptor α Antagonists Reveals the Key Common Structural Traits of Drugs Effectively Fighting Refractory Breast Cancers
- (2018) Matic Pavlin et al. Scientific Reports
- The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
- (2018) Pedram Razavi et al. CANCER CELL
- 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
- (2017) Hongchao Pan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Embryonic transcription factor SOX9 drives breast cancer endocrine resistance
- (2017) Rinath Jeselsohn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical Implications of ESR1 Mutations in Hormone Receptor-Positive Advanced Breast Cancer
- (2017) Tomas Reinert et al. Frontiers in Oncology
- ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling
- (2016) Luca Gelsomino et al. BREAST CANCER RESEARCH AND TREATMENT
- PlasmaESR1Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer
- (2016) Charlotte Fribbens et al. JOURNAL OF CLINICAL ONCOLOGY
- ActivatingESR1Mutations Differentially Affect the Efficacy of ER Antagonists
- (2016) Weiyi Toy et al. Cancer Discovery
- ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients
- (2015) D. Chu et al. CLINICAL CANCER RESEARCH
- Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients
- (2015) P. Wang et al. CLINICAL CANCER RESEARCH
- Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)
- (2015) Donavan T. Cheng et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer
- (2015) Rinath Jeselsohn et al. Nature Reviews Clinical Oncology
- Droplet digital polymerase chain reaction assay for screening of ESR1 mutations in 325 breast cancer specimens
- (2015) Takashi Takeshita et al. Translational Research
- Emergence of Constitutively Active Estrogen Receptor- Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast Cancer
- (2014) R. Jeselsohn et al. CLINICAL CANCER RESEARCH
- D538G Mutation in Estrogen Receptor- : A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer
- (2013) K. Merenbakh-Lamin et al. CANCER RESEARCH
- ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
- (2013) Weiyi Toy et al. NATURE GENETICS
- Activating ESR1 mutations in hormone-resistant metastatic breast cancer
- (2013) Dan R Robinson et al. NATURE GENETICS
- Absolute quantification by droplet digital PCR versus analog real-time PCR
- (2013) Christopher M Hindson et al. NATURE METHODS
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Absence of the K303R estrogen receptor α mutation in breast cancer patients exhibiting different responses to aromatase inhibitor anastrozole neoadjuvant treatment
- (2010) CHIARA GHIMENTI et al. Experimental and Therapeutic Medicine
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started